Back to mobile site

ResMed, Inc. (RMD) Misses Q2 EPS by 3c

January 23, 2014 4:19 PM EST Send to a Friend
ResMed, Inc. (NYSE: RMD) reported Q2 EPS of $0.60, $0.03 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login